ClearBridge Investments’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,584
| Closed | -$242K | – | 707 |
|
|
2024
Q4 | $242K | Sell |
1,584
-600,402
| -100% | -$101M | ﹤0.01% | 698 |
|
|
2024
Q3 | $117M | Sell |
601,986
-866,836
| -59% | -$181M | 0.09% | 213 |
|
|
2024
Q2 | $341M | Sell |
1,468,822
-92,838
| -6% | -$20.2M | 0.28% | 92 |
|
|
2024
Q1 | $337M | Sell |
1,561,660
-117,642
| -7% | -$27.6M | 0.27% | 100 |
|
|
2023
Q4 | $435M | Sell |
1,679,302
-143,880
| -8% | -$35.3M | 0.37% | 73 |
|
|
2023
Q3 | $469M | Sell |
1,823,182
-4,482
| -0.2% | -$1.2M | 0.45% | 61 |
|
|
2023
Q2 | $521M | Sell |
1,827,664
-37,081
| -2% | -$11M | 0.47% | 57 |
|
|
2023
Q1 | $518M | Buy |
1,864,745
+59,170
| +3% | +$16.4M | 0.5% | 56 |
|
|
2022
Q4 | $500M | Sell |
1,805,575
-70,065
| -4% | -$19.8M | 0.49% | 61 |
|
|
2022
Q3 | $501M | Sell |
1,875,640
-91,570
| -5% | -$19.4M | 0.51% | 51 |
|
|
2022
Q2 | $401M | Sell |
1,967,210
-543,782
| -22% | -$111M | 0.37% | 76 |
|
|
2022
Q1 | $529M | Sell |
2,510,992
-12,410
| -0.5% | -$2.7M | 0.4% | 69 |
|
|
2021
Q4 | $605M | Sell |
2,523,402
-840,525
| -25% | -$216M | 0.41% | 61 |
|
|
2021
Q3 | $952M | Sell |
3,363,927
-201,185
| -6% | -$65.9M | 0.68% | 31 |
|
|
2021
Q2 | $1.23B | Sell |
3,565,112
-403,932
| -10% | -$122M | 0.86% | 20 |
|
|
2021
Q1 | $1.11B | Buy |
3,969,044
+370,371
| +10% | +$99.9M | 0.83% | 24 |
|
|
2020
Q4 | $881M | Sell |
3,598,673
-418,011
| -10% | -$108M | 0.68% | 31 |
|
|
2020
Q3 | $1.14B | Sell |
4,016,684
-63,962
| -2% | -$17.8M | 0.98% | 20 |
|
|
2020
Q2 | $1.09B | Sell |
4,080,646
-326,665
| -7% | -$98.2M | 0.99% | 20 |
|
|
2020
Q1 | $1.39B | Sell |
4,407,311
-730,787
| -14% | -$222M | 1.51% | 8 |
|
|
2019
Q4 | $1.51B | Sell |
5,138,098
-1,094,579
| -18% | -$304M | 1.25% | 12 |
|
|
2019
Q3 | $1.45B | Sell |
6,232,677
-46,421
| -0.7% | -$10.8M | 1.27% | 13 |
|
|
2019
Q2 | $1.47B | Sell |
6,279,098
-2,313,259
| -27% | -$534M | 1.27% | 9 |
|
|
2019
Q1 | $2.03B | Sell |
8,592,357
-137,488
| -2% | -$43.3M | 1.79% | 4 |
|
|
2018
Q4 | $2.63B | Sell |
8,729,845
-115,604
| -1% | -$36.9M | 2.66% | 3 |
|
|
2018
Q3 | $3.13B | Sell |
8,845,449
-683,638
| -7% | -$235M | 2.69% | 3 |
|
|
2018
Q2 | $2.77B | Buy |
9,529,087
+340,828
| +4% | +$95.8M | 2.26% | 5 |
|
|
2018
Q1 | $2.52B | Buy |
9,188,259
+46,608
| +0.5% | +$14.5M | 2.37% | 3 |
|
|
2017
Q4 | $2.91B | Sell |
9,141,651
-109,176
| -1% | -$35M | 2.69% | 3 |
|
|
2017
Q3 | $2.9B | Sell |
9,250,827
-43,073
| -0.5% | -$12.8M | 2.79% | 3 |
|
|
2017
Q2 | $2.52B | Buy |
9,293,900
+172,875
| +2% | +$45.7M | 2.48% | 3 |
|
|
2017
Q1 | $2.49B | Buy |
9,121,025
+351,224
| +4% | +$99.3M | 2.51% | 3 |
|
|
2016
Q4 | $2.49B | Buy |
8,769,801
+302,218
| +4% | +$89.6M | 2.73% | 3 |
|
|
2016
Q3 | $2.65B | Buy |
8,467,583
+195,904
| +2% | +$58M | 2.98% | 3 |
|
|
2016
Q2 | $2B | Sell |
8,271,679
-193,780
| -2% | -$51.1M | 2.36% | 3 |
|
|
2016
Q1 | $2.2B | Sell |
8,465,459
-104,449
| -1% | -$27.6M | 2.63% | 3 |
|
|
2015
Q4 | $2.63B | Sell |
8,569,908
-13,716
| -0.2% | -$3.94M | 3.04% | 3 |
|
|
2015
Q3 | $2.5B | Buy |
8,583,624
+581,757
| +7% | +$192M | 3% | 3 |
|
|
2015
Q2 | $3.23B | Sell |
8,001,867
-23,374
| -0.3% | -$9.38M | 3.42% | 2 |
|
|
2015
Q1 | $3.39B | Sell |
8,025,241
-206,429
| -3% | -$81.4M | 3.52% | 2 |
|
|
2014
Q4 | $2.79B | Buy |
8,231,670
+341,907
| +4% | +$111M | 2.94% | 2 |
|
|
2014
Q3 | $2.61B | Sell |
7,889,763
-4,111
| -0.1% | -$1.36M | 2.87% | 2 |
|
|
2014
Q2 | $2.49B | Buy |
7,893,874
+190,390
| +2% | +$57.3M | 2.8% | 1 |
|
|
2014
Q1 | $2.36B | Sell |
7,703,484
-500,849
| -6% | -$159M | 2.8% | 2 |
|
|
2013
Q4 | $2.29B | Sell |
8,204,333
-22,029
| -0.3% | -$5.7M | 2.86% | 1 |
|
|
2013
Q3 | $1.98B | Sell |
8,226,362
-38,894
| -0.5% | -$8.7M | 2.77% | 1 |
|
|
2013
Q2 | $1.78B | Buy |
+8,265,256
| New | +$1.77B | 2.72% | 1 |
|
Other funds holding BIIB
ClearBridge Investments's BIIB Position: Q1 2025 in Review
ClearBridge Investments sold out of Biogen (BIIB) in Q1 2025, closing a stake of 1,584 shares — an estimated $242K sold.
ClearBridge Investments first reported a position in BIIB in Q2 2013 and held it in 47 quarters. The position peaked at $3.39B in Q1 2015. 880 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.
- ClearBridge Investments reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
- ClearBridge Investments sold 1,584 Biogen shares in Q1 2025, an estimated $242K.
- ClearBridge Investments first reported a position in Biogen in Q2 2013 and held it in 47 quarters.
- ClearBridge Investments's Biogen position peaked at $3.39B in Q1 2015.
- 880 funds tracked by Wall St. Rank held Biogen as of Q1 2025.
Based on ClearBridge Investments's 13F filing for Q1 2025, filed 13 May 2025.